Dr. Lovell is the President of AcraPharm Consulting, Inc. a company that provides project management and technical consulting services in pharmaceutical product development.

Previously, Dr. Lovell was the General Manager of BioDevelopment Laboratories, an operating unit of Genzyme Transgenics Corporation (GTC). Dr. Lovell managed a contract formulation development group that provided analytical methods development and validation, preformulation, formulation and dosage form stability (product development) services to the pharmaceutical industry.

Prior to its purchase by GTC, Dr. Lovell was a Vice President and one of three Principals of BioDevelopment Laboratories, Inc., a former Division of Arthur D. Little, Inc. BioDevelopment Laboratories, Inc. provided product development and product safety assessment services to the pharmaceutical, chemical and medical device industries.

Prior to participating in the purchase and founding of BioDevelopment Laboratories, Inc. Dr. Lovell was a Senior Consultant in Arthur D. Little’s Product Development Section. He joined the Food and Pharmaceutical Product Development Unit of the company in 1990 to lead a major business expansion in process and product development for pharmaceuticals, cosmetics, and medical nutritionals. Dr. Lovell expanded this business from less than $200,000 in 1990 to over $1.5 million in 1993. His major interests are the development of new dosage forms for drug delivery to achieve specific goals such as taste- masking, sustained/controlled-release, and improved bioavailability. Additional interests are development of new dosage forms for parenteral, oral, and subcutaneous administration to human and veterinary subjects.

Dr. Lovell has over twenty-five years experience in pharmaceutical product development and consulting. Prior to joining Arthur D. Little, Inc. he was a group leader in the Drug Delivery Systems Research Department of Abbott Laboratories. He held positions of research investigator and senior research scientist at G. D. Searle and Bristol-Myers, respectively.

Dr. Lovell received his Ph.D. in Pharmaceutical Analysis from the College of Pharmacy, University of Florida and a B.S. in Pharmacy (Cum Laude) from the Massachusetts College of Pharmacy & Allied Health Sciences.